Gonadotropin-releasing hormone antagonist associated with lower cardiovascular risk compared with gonadotropin-releasing hormone agonist in prostate cancer: A nationwide cohort and in vitro study.
Dong-Yi ChenPo-Jung SuLai-Chu SeeJia-Rou LiuCheng-Keng ChuangSee-Tong PangChi-Nan TsengShao-Wei ChenI-Chang HsiehPao-Hsien ChuYung-Chang LinCheng-Lung HsuJohn Wen-Cheng ChangMiao-Sui LinJong-Hwei S PangMing-Jer HsiehWen-Kuan HuangPublished in: The Prostate (2021)
GnRH antagonists were associated with reduced risk CV events compared with the GnRHa among patients with PCa, which may be through effects on macrophages.
Keyphrases